Charles River Laboratories International (CRL) Net Income towards Common Stockholders Growth (3y) (2012 - 2025)
Charles River Laboratories International (CRL) Net Income towards Common Stockholders Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -35.92% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 8.73% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -10.37% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 9.16% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 3.93% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -21.46% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 14.66% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 254.81% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -3.48% |
| 10 | Charles River Laboratories International | 9.23 Bn | 9.02 Bn | 744.94 Mn | -51.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -51.28% |
| Sep 27, 2025 | -17.70% |
| Jun 28, 2025 | -22.09% |
| Mar 29, 2025 | -35.57% |
| Dec 28, 2024 | -52.44% |
| Sep 28, 2024 | -13.24% |
| Jun 29, 2024 | 0.03% |
| Mar 30, 2024 | 1.74% |
| Dec 30, 2023 | 9.07% |
| Sep 30, 2023 | -5.21% |
| Jul 1, 2023 | 12.76% |
| Apr 1, 2023 | 26.59% |
| Jun 26, 2021 | 288.87% |
| Mar 27, 2021 | 1,306.40% |
| Dec 26, 2020 | 1,744.09% |
| Sep 26, 2020 | 1,280.87% |
| Jun 27, 2020 | 884.79% |
| Mar 28, 2020 | 2,233.80% |
| Jun 30, 2018 | -68.41% |
| Mar 31, 2018 | -26.01% |